The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee

Completed · Not applicable

Conditions studied: Peripheral Arterial Disease, Cardiovascular Disease, Peripheral Vascular Disease

In brief

The purpose of this study is to assess the safety and efficacy of paclitaxel administration using the occlusion perfusion catheter (OPC) for the prevention of restenosis in infrainguinal de novo, restenotic femoropopliteal and infrapopliteal stenoses and occlusions, and in-stent restenosis.

Key facts

Study ID
NCT02464501
Run by
Horizons International Peripheral Group
People needed
112
Starts
2015-05-20
Expected to finish
2019-11-01
Last updated by the study team
2019-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.